Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT03772925 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

NIH

Sponsor class

Stopped Drug supply issues

Conditions

Recurrent Acute Myeloid Leukemia
Recurrent Myelodysplastic Syndrome
Refractory Acute Myeloid Leukemia
Refractory Myelodysplastic Syndrome

Interventions

DRUG: Belinostat
DRUG: Pevonedistat

Sponsor

National Cancer Institute (NCI)